Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Tesla
TSLA
|
$875M |
| 2 |
Advanced Micro Devices
AMD
|
$777M |
| 3 |
Home Depot
HD
|
$564M |
| 4 |
Meta Platforms (Facebook)
META
|
$505M |
| 5 |
Merck
MRK
|
$403M |
Top Sells
| 1 |
Microsoft
MSFT
|
$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
$445M |
| 3 |
Chevron
CVX
|
$395M |
| 4 |
Micron Technology
MU
|
$379M |
| 5 |
Medtronic
MDT
|
$370M |
Sector Composition
| 1 | Healthcare | 18.68% |
| 2 | Technology | 14.97% |
| 3 | Consumer Discretionary | 11.35% |
| 4 | Consumer Staples | 10.73% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Vertex Pharmaceuticals
VRTX
$102B
| $446M | 0.52% |
1,707,368
+80,500
| +5% | +$21M |
|
27
GSK
GSK
$79B
| $436M | 0.51% |
10,011,921
-213,500
| -2% | -$9.3M |
|
28
Colgate-Palmolive
CL
$67.2B
| $431M | 0.51% |
5,688,786
+3,427,400
| +152% | +$260M |
|
29
Domino's
DPZ
$15.8B
| $424M | 0.5% |
1,040,825
+84,947
| +9% | +$34.6M |
|
|
30
Merck
MRK
$212B
| $418M | 0.49% |
5,099,334
+4,915,334
| +2,671% | +$403M |
|
31
Wells Fargo
WFC
$261B
| $407M | 0.48% |
8,390,611
+7,859,100
| +1,479% | +$381M |
|
32
Exelixis
EXEL
$10B
| $382M | 0.45% |
16,862,278
-238,500
| -1% | -$5.41M |
|
33
Alphabet (Google) Class C
GOOG
$2.77T
| $377M | 0.44% |
134,985
-25,800
| -16% | -$72.1M |
|
34
National Grid
NGG
$68B
| $375M | 0.44% |
4,874,077
-51,191
| -1% | -$3.94M |
|
35
Incyte
INCY
$17B
| $373M | 0.44% |
4,697,633
+106,900
| +2% | +$8.49M |
|
36
Abbott
ABT
$228B
| $372M | 0.44% |
3,140,866
+1,568,700
| +100% | +$186M |
|
37
Target
TGT
$41.7B
| $355M | 0.42% |
1,672,320
+15,600
| +0.9% | +$3.31M |
|
38
Roku
ROKU
$14.4B
| $352M | 0.41% |
2,808,100
+2,486,100
| +772% | +$311M |
|
39
PepsiCo
PEP
$203B
| $328M | 0.38% |
1,958,643
+817,581
| +72% | +$137M |
|
40
Lowe's Companies
LOW
$145B
| $321M | 0.38% |
1,586,400
+1,566,700
| +7,953% | +$317M |
|
41
Fortinet
FTNT
$58.7B
| $320M | 0.38% |
937,789
-75,000
| -7% | -$25.6M |
|
42
Alcoa
AA
$7.97B
| $319M | 0.37% |
+3,539,596
| New | +$319M |
|
43
Coca-Cola
KO
$294B
| $313M | 0.37% |
5,052,156
-4,762,950
| -49% | -$295M |
|
44
Pfizer
PFE
$142B
| $311M | 0.37% |
+6,011,941
| New | +$311M |
|
45
Icon
ICLR
$14B
| $311M | 0.36% |
1,276,958
-140,800
| -10% | -$34.2M |
|
46
AstraZeneca
AZN
$253B
| $303M | 0.36% |
4,561,828
-1,257,000
| -22% | -$83.4M |
|
47
General Mills
GIS
$26.2B
| $300M | 0.35% |
4,431,688
+131,500
| +3% | +$8.91M |
|
48
Novartis
NVS
$248B
| $297M | 0.35% |
3,381,170
-346,400
| -9% | -$30.4M |
|
49
ZIM Integrated Shipping Services
ZIM
$1.62B
| $295M | 0.35% |
4,062,538
+2,540,500
| +167% | +$185M |
|
50
Charter Communications
CHTR
$35.5B
| $295M | 0.35% |
541,400
+445,200
| +463% | +$243M |
|